Skip to content

Opus Genetics IRD Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$65.54M-700%-$16.52M+53.0%-$17.45M-132%-$7.42M+4.4%-$8.19M-15.3%
$13K0.0%$13K+30.0%$13K$14K$13K
$1.46M+60.4%$774K-2.6%$816K+5.2%$896K+11.2%$913K-7.3%
-$12.73M-41.5%-$9.83M-32.2%-$6.16M-20.0%-$10.27M-40.8%-$8.99M-57.3%
$0-100%$0-100%$0-100%$0-100%
$0$0-100%$0$0$0
$27.6M+34.8%$24.11M$4.54M+1,187%$906K-41.2%$20.47M+761%
$14.87M+29.6%$14.28M+326%$11.47M+443%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Opus Genetics generate?
Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
Where does Opus Genetics's cash flow data come from?
Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.